Atlas Trials

Docetaxel and S-1 Combination Therapy as Second-line Treatment for Advanced Gastric Cancer

Clinical trial NCT03137004 · UNKNOWN

Trial details

NCT number
NCT03137004
Sponsor
Fujian Cancer Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Advanced Gastric Cancer
Start date
2017-06-01
Primary completion
2018-04-10
Enrollment
47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.